PURPOSE: To characterize scleral biomechanics in both eyes of eight monkeys in which chronic intraocular pressure (IOP) elevation was induced in one eye. METHODS: Each posterior sclera was mounted on a pressurization apparatus, IOP was elevated from 5 to 45 mm Hg while the 3D displacements of the scleral surface were measured by speckle interferometry. Finite element (FE) models of each scleral shell were constructed that incorporated stretch-induced stiffening and multidirectionality of the collagen fibers. FE model predictions were then iteratively matched to experimental displacements to extract unique sets of scleral biomechanical properties. RESULTS: For all eyes, the posterior sclera exhibited inhomogeneous, anisotropic, nonlinear biomechanical behavior. Biomechanical changes caused by chronic IOP elevation were complex and specific to each subject. Specifically: (1) Glaucomatous eyes in which the contralateral normal eyes displayed large modulus or thickness were less prone to biomechanical changes; (2) glaucomatous scleral modulus associated with an IOP of 10 mm Hg decreased (when compared with that of the contralateral normal) after minimal chronic IOP elevation; (3) glaucomatous scleral modulus associated with IOPs of 30 and 45 mm Hg increased (when compared with that of the contralateral normal) after moderate IOP elevation; and (4) FE-based estimates of collagen fiber orientation demonstrated no change in the glaucomatous eyes. CONCLUSIONS: Significant stiffening of the sclera follows exposure to moderate IOP elevations in most eyes. Scleral hypercompliance may precede stiffening or be a unique response to minimal chronic IOP elevation in some eyes. These biomechanical changes are likely to be the result of scleral extracellular matrix remodeling.
PURPOSE: To characterize scleral biomechanics in both eyes of eight monkeys in which chronic intraocular pressure (IOP) elevation was induced in one eye. METHODS: Each posterior sclera was mounted on a pressurization apparatus, IOP was elevated from 5 to 45 mm Hg while the 3D displacements of the scleral surface were measured by speckle interferometry. Finite element (FE) models of each scleral shell were constructed that incorporated stretch-induced stiffening and multidirectionality of the collagen fibers. FE model predictions were then iteratively matched to experimental displacements to extract unique sets of scleral biomechanical properties. RESULTS: For all eyes, the posterior sclera exhibited inhomogeneous, anisotropic, nonlinear biomechanical behavior. Biomechanical changes caused by chronic IOP elevation were complex and specific to each subject. Specifically: (1) Glaucomatous eyes in which the contralateral normal eyes displayed large modulus or thickness were less prone to biomechanical changes; (2) glaucomatous scleral modulus associated with an IOP of 10 mm Hg decreased (when compared with that of the contralateral normal) after minimal chronic IOP elevation; (3) glaucomatous scleral modulus associated with IOPs of 30 and 45 mm Hg increased (when compared with that of the contralateral normal) after moderate IOP elevation; and (4) FE-based estimates of collagen fiber orientation demonstrated no change in the glaucomatous eyes. CONCLUSIONS: Significant stiffening of the sclera follows exposure to moderate IOP elevations in most eyes. Scleral hypercompliance may precede stiffening or be a unique response to minimal chronic IOP elevation in some eyes. These biomechanical changes are likely to be the result of scleral extracellular matrix remodeling.
Authors: Oliver Kessler; Elvis Lacatusu; Mark B Sommers; Eckard Mayr; Michael Bottlang Journal: Clin Biomech (Bristol, Avon) Date: 2006-03-22 Impact factor: 2.063
Authors: F J Ollivier; D E Brooks; M E Kallberg; H L Sapp; A M Komáromy; G R Stevens; W W Dawson; M B Sherwood; G N Lambrou Journal: Vet Ophthalmol Date: 2004 Jan-Feb Impact factor: 1.644
Authors: Anthony J Bellezza; Christopher J Rintalan; Hilary W Thompson; J Crawford Downs; Richard T Hart; Claude F Burgoyne Journal: Invest Ophthalmol Vis Sci Date: 2003-02 Impact factor: 4.799
Authors: Ian A Sigal; Richard A Bilonick; Larry Kagemann; Gadi Wollstein; Hiroshi Ishikawa; Joel S Schuman; Jonathan L Grimm Journal: Invest Ophthalmol Vis Sci Date: 2012-05-04 Impact factor: 4.799
Authors: Ian A Sigal; Hongli Yang; Michael D Roberts; Jonathan L Grimm; Claude F Burgoyne; Shaban Demirel; J Crawford Downs Journal: Invest Ophthalmol Vis Sci Date: 2011-11-21 Impact factor: 4.799
Authors: Michaël J A Girard; Nicholas G Strouthidis; Adrien Desjardins; Jean Martial Mari; C Ross Ethier Journal: J R Soc Interface Date: 2013-07-24 Impact factor: 4.118
Authors: Forest L Danford; Dongmei Yan; Robert A Dreier; Thomas M Cahir; Christopher A Girkin; Jonathan P Vande Geest Journal: Invest Ophthalmol Vis Sci Date: 2013-12-03 Impact factor: 4.799
Authors: Jacek K Pijanka; Petar P Markov; Dan Midgett; Neil G Paterson; Nick White; Emma J Blain; Thao D Nguyen; Harry A Quigley; Craig Boote Journal: J Biophotonics Date: 2019-01-10 Impact factor: 3.207
Authors: J Crawford Downs; Claude F Burgoyne; William P Seigfreid; Juan F Reynaud; Nicholas G Strouthidis; Verney Sallee Journal: Invest Ophthalmol Vis Sci Date: 2011-09-21 Impact factor: 4.799
Authors: Mary E Pease; Ericka N Oglesby; Elizabeth Cone-Kimball; Joan L Jefferys; Matthew R Steinhart; Anthony J Kim; Justin Hanes; Harry A Quigley Journal: Invest Ophthalmol Vis Sci Date: 2014-04-21 Impact factor: 4.799